HUMIRA

Abbvie Corporation🇨🇦 Health Canada

Approval Id: bf702be69b7ac91e
Drug Approval Canada Name: HUMIRA
Product Name: HUMIRA
Status: Marketed
Status Date: 2020-08-18
Original Market Date: 2020-08-18
Din: 02474263
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.16.92
Atc Original: L04AB04 ADALIMUMAB
Atc Name: l 04 ab 04
Aig Number: 0150364002
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

ADALIMUMAB

20 MG / 0.2 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bf702be69b7ac91e

Type

Standard